205 related articles for article (PubMed ID: 19069494)
1. [Prostamol-Uno treatment in patients with prostatic adenoma and chronic non-infectious prostatitis].
Trapeznikova MF; Dutov VV; Dolgovq AG; Urenkov SB
Urologiia; 2008; (5):39-42. PubMed ID: 19069494
[TBL] [Abstract][Full Text] [Related]
2. [Expediency of switching from combined therapy with prostamol Uno and alpha-1-adrenoblockers to monotherapy with prostamol Uno in patients with prostatic adenoma].
Razumov SV; Egorov AA
Urologiia; 2007; (3):47-50. PubMed ID: 17724829
[TBL] [Abstract][Full Text] [Related]
3. [Results of three-year clinical study of prostamol uno efficacy and safety in patients with initial symptoms of prostatic adenoma and risk of its progression].
Vinarov AZ; Aliaev IuG; Apolikhin OI; Mazo EB; Darenkov SP; Demidko IuL; Lokshin KL; Medvedev AA; Permiakova OV; Spivak LG; Shkol'nikov ME
Urologiia; 2010; (6):3-10. PubMed ID: 21433319
[TBL] [Abstract][Full Text] [Related]
4. [Efficiency and safety of prostamol-Uno in patients with chronic abacterial prostatitis].
Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
Urologiia; 2006; (1):47-50. PubMed ID: 16550824
[TBL] [Abstract][Full Text] [Related]
5. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic prostatitis in prophylaxis of prostatic adenoma].
Aliaev IuG; Vinarov AZ; Demidko IuL; Spivak LG
Urologiia; 2012; (2):39-40, 42-3. PubMed ID: 22876632
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of prostatic adenoma with concomitant chronic bacterial prostatitis].
Davidov MI
Urologiia; 2011; (1):21-8. PubMed ID: 21500490
[TBL] [Abstract][Full Text] [Related]
8. [Role of cytokines in the diagnosis of chronic prostatitis].
Razumov SV; Medvedev AA; Chirun NV; Sivkov AV; Oshchepkov VN; Siniukhin VN
Urologiia; 2003; (6):25-8. PubMed ID: 14708240
[TBL] [Abstract][Full Text] [Related]
9. Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.
Giulianelli R; Pecoraro S; Sepe G; Leonardi R; Gentile BC; Albanesi L; Brunori S; Mavilla L; Pisanti F; Giannella R; Morello P; Tuzzolo D; Coscione M; Galasso F; D'Angelo T; Ferravante P; Morelli E; Miragliuolo A;
Arch Ital Urol Androl; 2012 Jun; 84(2):94-8. PubMed ID: 22908779
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of prostamol-UNO in the treatment of patients with initial symptoms of prostatic adenoma and risk of progression: 2 years of investigations].
Aliaev IuG; Apolikhin OI; Mazo EB; Vinarov AZ; Lokshin KL; Medvedev AA; Permiakova OV; Spivak LG; Shkol'nikov ME
Urologiia; 2009; (4):36-40. PubMed ID: 19824382
[TBL] [Abstract][Full Text] [Related]
11. [Cernilton in the treatment of prostatic adenoma and chronic prostatitis].
Aslamazov EG; Akhvlediani ND; Vinarov AZ; Aliaev IuG
Urologiia; 2007; (1):52, 54-6. PubMed ID: 17472001
[TBL] [Abstract][Full Text] [Related]
12. [Experience in vitaprost treatment of patients with chronic abacterial prostatitis and prostatic adenoma after prostatic arteries embolism].
Iakovets IaV; Iakovets EA; Neĭmark AI; Karpenko AA; Arzamastsev DD
Urologiia; 2011; (5):33-4, 36-9. PubMed ID: 22279784
[TBL] [Abstract][Full Text] [Related]
13. [Prostagut forte treatment of patients with prostatic adenoma with comorbid chronic prostatitis].
Avdoshin VP; Pul'bere SA
Urologiia; 2012; (2):44, 46-7. PubMed ID: 22876633
[TBL] [Abstract][Full Text] [Related]
14. [Retropubic adenomectomy in patients with a high level of prostate-specific antigen after prostatic biopsy].
Veliev EI; Kotov SV; Golubtsova EN; Sokolov AE; Bogdanov AB; Avakian AIu
Urologiia; 2012; (1):59-63. PubMed ID: 22646005
[TBL] [Abstract][Full Text] [Related]
15. Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment.
Suardi N; Gandaglia G; Nini A; Montorsi F; Pellucchi F; Agostini A; Rigatti P
Minerva Urol Nefrol; 2014 Jun; 66(2):119-25. PubMed ID: 24988203
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of tulosine in patients with prostatic adenoma].
Gorilkovskiĭ LM; Zingerenko MB
Urologiia; 2009; (2):60, 62-5. PubMed ID: 19526876
[TBL] [Abstract][Full Text] [Related]
17. [Approaches to raising efficacy of treatment of patients with chronic prostatitis associated with intracellular infections].
Kul'chavenia EV; Breusov AA; Brizhatiuk EV; Kholtobin DP
Urologiia; 2010; (6):55-8. PubMed ID: 21427997
[TBL] [Abstract][Full Text] [Related]
18. Effects of prostatic inflammation on LUTS and alpha blocker treatment outcomes.
Lee HN; Kim TH; Lee SJ; Cho WY; Shim BS
Int Braz J Urol; 2014; 40(3):356-66. PubMed ID: 25010301
[TBL] [Abstract][Full Text] [Related]
19. [Vitaprost forte efficacy in patients with prostatic adenoma].
Tkachuk VN; Tkachuk IN
Urologiia; 2008; (4):34-7. PubMed ID: 19058362
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic prostatitis/chronic pelvic pain syndrome category IIIA with Serenoa repens plus selenium and lycopene (Profluss) versus S. repens alone: an Italian randomized multicenter-controlled study.
Morgia G; Mucciardi G; Galì A; Madonia M; Marchese F; Di Benedetto A; Romano G; Bonvissuto G; Castelli T; Macchione L; Magno C
Urol Int; 2010; 84(4):400-6. PubMed ID: 20332612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
